NCT06402994

Brief Summary

Hearing loss is one of the most prevalent impairments in the world. The World Health Organization estimates that as of 2020, around 466 million people worldwide are affected by disabling hearing loss, of which 34 million are children. Without appropriate diagnosis and treatment, hearing impairment can cause difficulties with communication, learning, social-emotional functioning, employment and quality of life. Early intervention is especially important for children, for whom unaddressed hearing loss has been proven to affect speech and language development, educational attainments, and social skills. Through early detection and interventions many of these impacts can be mitigated, highlighting the importance of accurate hearing diagnostics. Evaluation of speech intelligibility is a fundamental component of hearing assessment and rehabilitation. The current gold standard in measuring speech intelligibility relies heavily on behavioural tests. While these tests are reliable and fast in healthy adults, it is challenging to assess speech intelligibility for patients who cannot communicate clearly, such as young children. For example, behavioral tests require active participation from the patient, such as raising their hand when a sound is heard, or repeating words and sentences. Objective measures, for instance using electro-encephalography (EEG), could overcome the current challenges in hearing assessment and do not require active participation from the patient. For example, in Flanders, all newborns are screened with an objective test where a few sensors on the head detect brainwaves in response to sounds. However, objective tests only use simple sound stimuli, such as tones or clicks, which cannot be used to measure important high-level hearing outcomes, such as speech understanding. In other words, current objective tests are used to check if a person can hear a word, but they can't indicate if the person can understand the word. An obvious missing link in audiological practice is a diagnostic test that can measure high-level hearing outcomes such as speech understanding in an objective way. For this reason, CORGEE was developed. CORGEE uses a novel method of "neural speech tracking" to objectively measure speech intelligibility using EEG. In the current study, the efficacy and the clinical validity of the CORGEE software will be evaluated in young children with a hearing impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2025

Completed
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

April 22, 2024

Last Update Submit

September 2, 2025

Conditions

Keywords

speech intelligibilityEEGobjective measurehearing losshearing aid benefitchildren

Outcome Measures

Primary Outcomes (1)

  • Neural speech tracking

    Neural envelope tracking to conversational speech at different intensities. Here, neural envelope tracking represents the correlation between the original envelope (i.e. the envelope of the presented speech signal) and the reconstructed envelope (i.e., the envelope as calculated from the EEG)

    Baseline

Secondary Outcomes (1)

  • Speech intelligibility

    Baseline

Other Outcomes (1)

  • Questionnaires

    Up to 12 months

Study Arms (3)

Infants & toddlers

Children between 0 and 2,5 years of age

Other: Electrophysiological experiment

Kindergartners

Children between 2,5 and 6 years of age

Other: Electrophysiological experimentBehavioral: Speech audiometry

Primary school children

Children between 6 and 12 years of age

Other: Electrophysiological experimentBehavioral: Speech audiometry

Interventions

Neural envelope tracking to conversational speech at different intensities

Also known as: Use of the CORGEE software
Infants & toddlersKindergartnersPrimary school children

Speech perception assessment at different intensities

KindergartnersPrimary school children

Eligibility Criteria

Age0 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with a bilateral hearing impairment in Flanders

You may qualify if:

  • Subcategory 1 (Infants \& toddlers)
  • ,5 years of age
  • Bilateral hearing loss OR
  • Suspicion of hearing loss (at least 1 criteria met): referred after FAIL on the new born hearing screening OR referred by the subject's paediatrician, general practitioner or otolaryngologist
  • Voluntary written informed consent of the legally authorised representative
  • Subcategory 2 (Kindergartners)
  • ,5 - 6 years of age
  • Going to kindergarten
  • Bilateral hearing loss
  • Using hearing aids regularly for at least three months
  • Would be cooperative in behavioural testing
  • Knowledge of Dutch (at least 1 criteria met): Dutch as mother tongue OR enrolled in Dutch speaking education
  • Voluntary written informed consent of the legally authorised representative
  • Subcategory 3 (Primary school children)
  • years of age
  • +6 more criteria

You may not qualify if:

  • no exposure to Dutch
  • known brain injuries
  • acute illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

KOCA vzw

Antwerp, Antwerpen, 2018, Belgium

Location

CAR Sint-Lievenspoort

Ghent, Oost-Vlaanderen, 9000, Belgium

Location

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

CAR Overleie

Kortrijk, West-Vlaanderen, 8500, Belgium

Location

MeSH Terms

Conditions

Hearing LossSpeech Intelligibility

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpeechVerbal BehaviorCommunicationBehavior

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2024

First Posted

May 7, 2024

Study Start

February 28, 2024

Primary Completion

June 23, 2025

Study Completion

June 23, 2025

Last Updated

September 9, 2025

Record last verified: 2025-09

Locations